Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry: Notice of Charter Renewal, 5761 [2015-02026]
Download as PDF
<![CDATA[
5761
Federal Register / Vol. 80, No. 22 / Tuesday, February 3, 2015 / Notices
screened and selected from Individuals
and Households, Businesses,
Organizations, and/or State, Local or
Tribal Government. There is no cost to
respondents other than their time. The
estimated total burden hours for this
data collection activity are 268.
Type of collection
Average
number of
respondents
per activity
Annual
frequency
per response
Average
number of
activities
Average hours
per response
Online surveys, Telephone Surveys, Focus Groups, In person observation/
testing ...........................................................................................................
67
1
5
48/60
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2015–02062 Filed 2–2–15; 8:45 am]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; General Licensing
Provisions; Section 351(k) Biosimilar
Applications
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ACTION:
rljohnson on DSK3VPTVN1PROD with NOTICES
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
14:46 Feb 02, 2015
Jkt 235001
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the information collection in an
application for a proposed biosimilar
product and an application for a
supplement for a proposed
interchangeable product.
DATES: Submit either electronic or
written comments on the collection of
information by April 6, 2015.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA 305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
SUMMARY:
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the Board
of Scientific Counselors, National
Center for Environmental Health/
Agency for Toxic Substances and
Disease Registry, Department of Health
and Human Services, has been renewed
for a 2-year period through May 21,
2016.
For information, contact William
Cibulas, Ph.D., Designated Federal
Officer, Board of Scientific Counselors,
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry, Department of
Health and Human Services, 4770
Buford Highway, Mailstop F61,
Chamblee, Georgia 30341, telephone
(770) 488–0662 or fax (770) 488–3385.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
VerDate Sep<11>2014
Food and Drug Administration,
HHS.
Board of Scientific Counselors,
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry: Notice of
Charter Renewal
BILLING CODE 4163–18–P
[Docket No. FDA–2012–N–0129]
AGENCY:
Centers for Disease Control and
Prevention
[FR Doc. 2015–02026 Filed 2–2–15; 8:45 am]
Food and Drug Administration
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
SUPPLEMENTARY INFORMATION:
General Licensing Provisions; Section
351(k) Biosimilar Applications (OMB
Control Number 0910–0719)—Extension
The Patient Protection and Affordable
Care Act (Affordable Care Act) (Pub. L.
111–148) contains a subtitle called the
Biologics Price Competition and
Innovation Act of 2009 (BPCI Act),
which amends the Public Health Service
Act (PHS Act) and establishes an
abbreviated licensure pathway for
E:\FR\FM\03FEN1.SGM
03FEN1
]]>Agencies
[Federal Register Volume 80, Number 22 (Tuesday, February 3, 2015)]
[Notices]
[Page 5761]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-02026]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Environmental
Health/Agency for Toxic Substances and Disease Registry: Notice of
Charter Renewal
This gives notice under the Federal Advisory Committee Act (Pub. L.
92-463) of October 6, 1972, that the Board of Scientific Counselors,
National Center for Environmental Health/Agency for Toxic Substances
and Disease Registry, Department of Health and Human Services, has been
renewed for a 2-year period through May 21, 2016.
For information, contact William Cibulas, Ph.D., Designated Federal
Officer, Board of Scientific Counselors, National Center for
Environmental Health/Agency for Toxic Substances and Disease Registry,
Department of Health and Human Services, 4770 Buford Highway, Mailstop
F61, Chamblee, Georgia 30341, telephone (770) 488-0662 or fax (770)
488-3385.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2015-02026 Filed 2-2-15; 8:45 am]
BILLING CODE 4163-18-P
